Advertisement



Drug Recalls

Last updated

Every drug recall in FDA enforcement reports from the last three years, plus older recalls that are still open. Filter by severity, status or medicine, and check the lot numbers on your package.

3 Class I (most serious) drug recalls reported in the last 30 days.

3,250 recalls

  • Class II Ongoing

    Humanrace Suncare, Ozone Face Protection Daily Moisturizer, Broad Spectrum Sunscreen SPF 30, packaged as a 53mL (1.8 fl oz.) bottle, 100% mineral, Active Ingredient: Zinc oxide 15%, Snow Mushroom, Dist. By: @Humanrace 20…

    Reason: Subpotent Drug: Product does not contain SPF that is declared on the label.

    HUMANRACE

    Lots, distribution and details
    Product
    Humanrace Suncare, Ozone Face Protection Daily Moisturizer, Broad Spectrum Sunscreen SPF 30, packaged as a 53mL (1.8 fl oz.) bottle, 100% mineral, Active Ingredient: Zinc oxide 15%, Snow Mushroom, Dist. By: @Humanrace 2022 Beverly Hills, CA 90210, USA, NDC 82779-01
    Lots / codes
    Lot #: 1732A, 1732B, 1742A, 1742B, 1742C, 1742D; Exp. 06/2024.
    Distribution
    Nationwide in the USA, Spain, Italy, UK, and France.
    Quantity
    5046 units
    Recall started
    August 18, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1175-2023
  • Class I Ongoing

    SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover…

    Reason: Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.

    Novartis Pharmaceuticals Corp.

    Lots, distribution and details
    Product
    SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, NDC 0078-0110-22.
    Lots / codes
    FX001691, Exp. 12/31/2025
    Distribution
    Nationwide in the USA
    Quantity
    1272 bottles
    Recall started
    September 8, 2023 (Voluntary: Firm initiated)
    Severity
    Most serious: use could cause serious health problems or death.
    FDA recall number
    D-1174-2023
  • Class II Ongoing

    octiq Lubricating Eye Drops, Dextran 70.01%, Hypromellose 0.3%, 0.5 FL OZ Each (2X 15 mL Bottles), Manufactured for Innovus Pharmaceuticals, Inc., Englewood, CO 80112, Made in Jordan, NDC:57483-610-15.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: YM308 EXP:10/24;
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    30,490 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1167-2023
  • Class II Ongoing

    TRP Natural Eyes, Twitching Relief, Sterile Eye Ointment, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-099-15.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot:DD001 EXP: 07/24;
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    8,819
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1166-2023
  • Class II Ongoing

    TRP Natural Eyes, Stye Relief, Sterile Eye Ointment, Homeopathic 0.14 oz (4 grams), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-014-13.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot:182002 EXP: 11/24; Lot:182003 EXP: 11/24; Lot:182004 EXP: 12/24; Lot:182005 EXP:02/25; Lot:182006 EXP:02/25; Lot:182007EXP:02/25; Lot:182008 EXP:02/25; Lot:182009 EXP:02/25; Lot:182010 EXP:03/25: Lot:182011 EXP:03/25;
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    180,315 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1165-2023
  • Class II Ongoing

    TRP Natural Eyes, Red Eye Relief PF, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-095-19.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: IW001 EXP:07/24; Lot: IW002 EXP: 12/24
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    196,442 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1164-2023
  • Class II Ongoing

    TRP Natural Eyes, Red Eye Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-058-15.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: FQ001 EXP:07/24
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    8,868 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1163-2023
  • Class II Ongoing

    TRP Natural Eyes, Pink Eye Relief PF, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-094-19.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: FP001 EXP:07/24
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    8,873
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1162-2023
  • Class II Ongoing

    TRP Natural Eyes, Pink Eye Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-013-15.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: IV001 EXP:06/25; Lot:IV002 EXP: 11/24; Lot:IV004 EXP:01/25
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    293,400 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1161-2023
  • Class II Ongoing

    MAJOR LubriFresh P.M. Nighttime Ointment, Lubricant Eye Ointment, Sterile, 0.125 OZ (3.5g), Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, Made in Jordan, NDC: 0904-6488-38.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: 184001 EXP: 11/24; 184002 EXP: 11/24; 184003 EXP: 11/24; Lot: 184004 EXP: 12/24; Lot: 184005 EXP: 12/24; Lot:184006 EXP:12/24;
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    282,564 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1160-2023
  • Class II Ongoing

    TRP Natural Eyes, Floaters Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-098-15.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: DA001 EXP: 06/24; Lot: DA002 EXP: 11/24
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    18,171 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1159-2023
  • Class II Ongoing

    TRP Natural Eyes, Eye Lid Relief, Sterile Eye ointment, Homeopathic 0.14 oz (4 grams), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-165-13.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: 180001 EXP: 01/25
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    16,500 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1158-2023
  • Class II Ongoing

    TRP Natural Eyes, Eye Lid Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-417-19.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: FV005 EXP:03/25
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    8,000 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1157-2023
  • Class II Ongoing

    TRP Natural Eyes, Dryness Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-096-19.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: FR001 EXP: 07/24; Lot: FR004 EXP: 04/25; Lot:FR005 EXP: 04/25; Lot:FR006 EXP: 04/25; Lot: FR007 Exp: 04/25
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    83,898 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1156-2023
  • Class II Ongoing

    TRP Natural Eyes, Dryness Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC:17312-178-15.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: IX001 EXP: 07/24; Lot: IX002 EXP: 12/24
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    196,111 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1155-2023
  • Class II Ongoing

    TRP Natural Eyes, Blur Relief, Sterile Eye Drops, Homeopathic 0.5 FL OZ (15 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-002-11.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: DC001 EXP: 06/24
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    5,509
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1154-2023
  • Class II Ongoing

    TRP Natural Eyes, Allergy Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-097-19.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot: FT001; EXP: 07/24
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    8,810 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1153-2023
  • Class II Ongoing

    TRP Natural Eyes, Allergy Eyes Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-032-15.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Product
    TRP Natural Eyes, Allergy Eyes Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-032-15.
    Lots / codes
    Lot: IY001; EXP 07/24
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    8,747
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1152-2023
  • Class II Ongoing

    TRP Natural Eyes, Aging Eye Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-027-15.

    Reason: Lack of Assurance of Sterility

    AMMAN PHARMACEUTICAL INDUSTRIES

    Lots, distribution and details
    Lots / codes
    Lot#:DB001 EXP: 06/24
    Distribution
    Product was distributed to two (2) direct accounts in RI and CO.
    Quantity
    8,747 units
    Recall started
    September 1, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1151-2023
  • Class I Ongoing

    Vegetal Vigra, 200mg capsules, 8-count bottle, Manufacturer: Hand-shaking (Int'l) Corp. USA ADD: Hand-shaking Mansion, the 5th Ave., Stanford, USA. UPC 8 931028 556885

    Reason: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.

    APG SEVEN, INC

    Lots, distribution and details
    Lots / codes
    All lots, Expires: 01/31/2025
    Distribution
    Nationwide in the USA
    Quantity
    120 bottles
    Recall started
    August 3, 2023 (Voluntary: Firm initiated)
    Severity
    Most serious: use could cause serious health problems or death.
    FDA recall number
    D-1150-2023
  • Class II Ongoing

    All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

    Reason: CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

    Inmar Supply Chain Solutions, LLC

    Lots, distribution and details
    Lots / codes
    Miscellaneous
    Distribution
    Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
    Quantity
    Unknown
    Recall started
    August 14, 2023 (N/A)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1104-2023
  • Class III Ongoing

    Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale -Bardez, Goa 403513, India, Manufactured for Glenmark Pha…

    Reason: Subpotent: Out of Specification for Assay Test at the 3-month time point.

    Glenmark Pharmaceuticals Inc., USA · Trandolapril and Verapamil Hydrochloride

    Lots, distribution and details
    Product
    Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale -Bardez, Goa 403513, India, Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-295-01
    Lots / codes
    Batch # 19224744
    Distribution
    nationwide in the U.S.
    Quantity
    1,200 bottles
    Recall started
    August 14, 2023 (Voluntary: Firm initiated)
    Severity
    Not likely to cause health problems — for example a labelling or packaging fault.
    FDA recall number
    D-1095-2023
  • Class III Ongoing

    Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05

    Reason: Failed Impurities/Degradation Specifications

    ALEMBIC PHARMACEUTICALS, INC. · Tobramycin

    Lots, distribution and details
    Lots / codes
    Lot #: AMR103, Exp: 10/2023; Lot#: AMR201, Exp: 06/2024
    Distribution
    Nationwide in the USA
    Quantity
    82,400 bottles
    Recall started
    July 27, 2023 (Voluntary: Firm initiated)
    Severity
    Not likely to cause health problems — for example a labelling or packaging fault.
    FDA recall number
    D-1086-2023
  • Class II Ongoing

    Testosterone Cypionate-Testosterone Propionate 180-20 mg/mL in cottonseed oil, Compounded Rx, For Intramuscular Use Only, a) 1 mL, b) 5 mL Multi-Dose Vial, New Vitalis Pharmacy, 4139 Cadillac Ct, Ste 201, Louisville, KY…

    Reason: Lack of Assurance of Sterility

    New Vitalis Pharmacy LLC dba New Vitalis Pharmacy

    Lots, distribution and details
    Product
    Testosterone Cypionate-Testosterone Propionate 180-20 mg/mL in cottonseed oil, Compounded Rx, For Intramuscular Use Only, a) 1 mL, b) 5 mL Multi-Dose Vial, New Vitalis Pharmacy, 4139 Cadillac Ct, Ste 201, Louisville, KY 40213
    Lots / codes
    Lot #: AL-05222023@901, BUD 7/22/23; AL-06122023@908CS, BUD 8/11/23
    Distribution
    Nationwide
    Quantity
    102 vials
    Recall started
    July 13, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0944-2023
  • Class II Ongoing

    Diclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only, Manufactured for: Alembic Pharmaceuticals, Inc. Bedminster, NJ 07921, USA Manufactured by: Alembic Pharmaceuticals Limited (Derma Di…

    Reason: Defective Delivery System

    ALEMBIC PHARMACEUTICALS, INC. · Diclofenac Sodium

    Lots, distribution and details
    Product
    Diclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only, Manufactured for: Alembic Pharmaceuticals, Inc. Bedminster, NJ 07921, USA Manufactured by: Alembic Pharmaceuticals Limited (Derma Division) Karakhadi, Vadodara 391450, India. NDC 62332-487-12
    Lots / codes
    Lot #: 220151, 220152, 220153, Exp. Date 11/2024
    Distribution
    Nationwide within the United States
    Quantity
    2844 units
    Recall started
    June 22, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0941-2023

Have this medicine at home? Compare the lot number and expiry date on your package with the recall. Do not stop taking a prescribed medicine on your own — stopping suddenly can be riskier than the recalled lot. Your pharmacist can check it and usually swap it for an unaffected one.

What the recall classes mean

  • Class I Most serious: use could cause serious health problems or death.
  • Class II Could cause temporary or medically reversible health problems; serious harm is unlikely.
  • Class III Not likely to cause health problems — for example a labelling or packaging fault.

Source: FDA Enforcement Report, via openFDA. Updated here twice a day; last update November 4, 2026 14:40. openFDA data are not validated for clinical use — confirm with the FDA source or your pharmacist.

Advertisement